Hsu FT - Search Results

1

The inhibitory effect and mechanism of quetiapine on tumor progression in hepatocellular carcinoma in vivo.

Su CM, Lin SS, Wang HC, Hsu FT, Chung JG, Hsu LC. Su CM, et al. Among authors: hsu ft, hsu lc. Environ Toxicol. 2022 Jan;37(1):92-100. doi: 10.1002/tox.23380. Epub 2021 Oct 9. Environ Toxicol. 2022. PMID: 34626444 Free PMC article.

2

Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-κB pathway in hepatocellular carcinoma cells.

Chiang IT, Liu YC, Wang WH, Hsu FT, Chen HW, Lin WJ, Chang WY, Hwang JJ. Chiang IT, et al. Among authors: hsu ft. In Vivo. 2012 Jul-Aug;26(4):671-81. In Vivo. 2012. PMID: 22773582

3

Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.

Hsu FT, Liu YC, Chiang IT, Liu RS, Wang HE, Lin WJ, Hwang JJ. Hsu FT, et al. Int J Oncol. 2014 Jul;45(1):177-88. doi: 10.3892/ijo.2014.2423. Epub 2014 May 6. Int J Oncol. 2014. PMID: 24807012

4

Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.

Hsu FT, Chang B, Chen JC, Chiang IT, Liu YC, Kwang WK, Hwang JJ. Hsu FT, et al. Sci Rep. 2015 Oct 21;5:15391. doi: 10.1038/srep15391. Sci Rep. 2015. PMID: 26487364 Free PMC article.

5

Curcumin Sensitizes Hepatocellular Carcinoma Cells to Radiation via Suppression of Radiation-Induced NF-κB Activity.

Hsu FT, Liu YC, Liu TT, Hwang JJ. Hsu FT, et al. Biomed Res Int. 2015;2015:363671. doi: 10.1155/2015/363671. Epub 2015 Oct 11. Biomed Res Int. 2015. PMID: 26539482 Free PMC article.

6

Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.

Chen JC, Chuang HY, Hsu FT, Chen YC, Chien YC, Hwang JJ. Chen JC, et al. Among authors: hsu ft. Oncotarget. 2016 Dec 20;7(51):85450-85463. doi: 10.18632/oncotarget.13398. Oncotarget. 2016. PMID: 27863427 Free PMC article.

7

Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells.

Tsai JJ, Pan PJ, Hsu FT. Tsai JJ, et al. Among authors: hsu ft. Oncol Rep. 2017 Feb;37(2):1036-1044. doi: 10.3892/or.2016.5328. Epub 2016 Dec 20. Oncol Rep. 2017. PMID: 28000898

8

Amentoflavone Induces Apoptosis and Inhibits NF-ĸB-modulated Anti-apoptotic Signaling in Glioblastoma Cells.

Yen TH, Hsieh CL, Liu TT, Huang CS, Chen YC, Chuang YC, Lin SS, Hsu FT. Yen TH, et al. Among authors: hsu ft. In Vivo. 2018 Mar-Apr;32(2):279-285. doi: 10.21873/invivo.11235. In Vivo. 2018. PMID: 29475910 Free PMC article.

9

Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.

Weng MC, Wang MH, Tsai JJ, Kuo YC, Liu YC, Hsu FT, Wang HE. Weng MC, et al. Among authors: hsu ft. Biosci Rep. 2018 May 8;38(3):BSR20171264. doi: 10.1042/BSR20171264. Print 2018 Jun 29. Biosci Rep. 2018. PMID: 29535278 Free PMC article.

10

Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo.

Tsai JJ, Hsu FT, Pan PJ, Chen CW, Kuo YC. Tsai JJ, et al. Among authors: hsu ft. Anticancer Res. 2018 Apr;38(4):2119-2125. doi: 10.21873/anticanres.12452. Anticancer Res. 2018. PMID: 29599330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters